MacroGenics Inc. is slated to go public this week.
The Rockville drug-maker plans to raise as much as $73.6 million to fund the development of its pipeline, selling 4 million shares at a forecasted range of $14 to $16 per share. Shares of MGNX are expect to start trading Friday on the Nasdaq Stock Market.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2013/10/macrogenics-slated-to-go-public-this.html?ana=e_wash_rdup&s=newsletter&ed=2013-10-08{/iframe}